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Bmi-1 is a polycomb group protein that was identified as c-myc cooperating oncogene in murine lymphomagenesis. The current study
was undertaken to determine the role of Bmi-1 in human oral carcinogenesis. Bmi-1 protein and RNA expression levels were
markedly enhanced in the cells of oral squamous cell carcinomas (OSCC) compared with that of normal human oral keratinocytes
(NHOK). Enhanced-Bmi-1 expression was also detected in situ in the archived oral mucosal tissues with cancerous and precancerous
histopathology, including that of mild epithelial dysplasia. Thus, Bmi-1 expression occurs at a very early stage in oral carcinogenesis. To
determine the biological role of Bmi-1 in cell proliferation, endogenous Bmi-1 was knocked down in actively proliferating SCC4 cells
and NHOK by RNA interference. After Bmi-1 knockdown, cell replication was severely retarded. However, the expression of
p16
INK4A, a known cellular target of Bmi-1, was not changed in cells with or without Bmi-1 knockdown. Furthermore, Bmi-1
knockdown in HOK-16B-BaP-T cells, in which the p16
INK4A/pRb pathway was abrogated, led to immediate arrest of replication and
loss of viable cells. Thus, our data suggest that Bmi-1 may act through p16
INK4A-independent pathways to regulate cellular
proliferation during oral cancer progression.
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Bmi-1 is a polycomb group (PcG) transcription repressor
originally identified as a c-myc cooperating oncogene in murine
lymphomas (van Lohuizen et al, 1991; Pirrotta, 1998). Proliferative
capacity of leukaemic and normal haemopoietic stem cells derived
from Bmi-1
-/- mice was compromised, suggesting the possible role
of Bmi-1 in the maintenance of tumour stem cell phenotype
(Lessard and Sauvageau, 2003). Bmi-1 is one of the core subunits
of the polycomb repressive complex 1, which regulates the diverse
biological processes, including X chromosome inactivation,
carcinogenesis, and stem cell renewal (Li et al, 2006; Sparmann
and van Lohuizen, 2006). Cellular target genes of Bmi-1 have been
identified and include ink4a and ink4b loci, encoding p16
INK4A,
p19
ARF, and p15
INK4B (Jacobs et al, 1999). Bmi-1 is believed to
promote cellular proliferation by repressing the expression of the
ink4a locus, which plays pivotal roles in the onset of cellular
senescence in many different types of human somatic cells
(reviewed in Itahana et al, 2004). During normal replication of
primary human cells, Bmi-1 expression level is decreased notably
in senescent cells (Itahana et al, 2003). When overexpressed,
Bmi-1 is able to extend the replicative life span of human diploid
fibroblasts (Itahana et al, 2003) and immortalise the post-selection
population of human mammary epithelial cells by activation of
endogenous telomerase gene, hTERT (Dimri et al, 2002). There-
fore, in normal human cells, downregulation of Bmi-1 expression
may be important for the establishment of the senescence
program.
Cellular senescence is physiologically important because it is a
potent tumor suppressor mechanism that must be overcome for
cells to be immortalised and transformed (Campisi, 2005; Dimri,
2005). The molecular mechanisms of senescence have therefore
been investigated extensively and yielded several important
regulators of senescence (Itahana et al, 2004). The intrinsic,
telomere-dependent senescence is triggered by accumulation of
shortened and dysfunctional telomeres with altered telomeric state
(Harley et al, 1990; Karlseder et al, 2002). The extrinsic senescence
is telomere-independent and triggered in cells after exposure to
environmental factors, such as genotoxic stress, in vitro culture
shock, and oncogenic stimuli (Serrano et al, 1997; Ramirez et al,
2001; Itahana et al, 2004; Chen et al, 2005; Dimri, 2005). The onset
of extrinsic senescence is frequently associated with induction
of p16
INK4A (Itahana et al, 2004). The mechanisms resulting in
p16
INK4A upregulation during senescence are not fully understood,
although recent studies found a positive control by ETS1 and
negative regulation of its expression by Id-1, Bmi-1, and CBX7
(Ohtani et al, 2001; Itahana et al, 2003; Gil et al, 2004). In
particular, Bmi-1 overexpression is detected in several types of
human cancers (Bea et al, 2001; Kim et al, 2004a,b; Breuer et al,
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s2005), leading to the hypothesis that Bmi-1 facilitates tumorigenesis
by nullifying the p16
INK4A-mediated extrinsic senescence pathway.
The current study was undertaken to investigate the role of
Bmi-1 in oral carcinogenesis and its functional relationship with
p16
INK4A. We report enhanced expression of Bmi-1 in preneoplas-
tic and cancerous oral epithelial tissues compared with the normal
counterparts. The cell lines established from oral squamous cell
carcinomas (OSCC) also expressed notably higher level of Bmi-1
compared with those of normal human oral keratinocytes
(NHOK). However, the expression levels of Bmi-1 and p16
INK4A
were poorly correlated in the OSCC cells. Knockdown of
endogenous Bmi-1 led to rapid inhibition of cell proliferation in
the OSCC cells, regardless of the presence of functional p16
INK4A/
pRb cell cycle inhibitory pathway in these cells. Thus, our results
indicate that Bmi-1 may act through p16
INK4A-independent path-
ways to regulate cellular proliferation during oral carcinogenesis.
MATERIALS AND METHODS
Cells and cell culture
Primary NHOK cultures were prepared from separated keratinis-
ing oral epithelial tissue discarded during routine oral surgery
procedures. The cells were cultured in keratinocyte growth
medium (KGM) containing a low level (0.15mM)o fC a
þþ and
supplementary growth factor bullet kit (Cambrex, East Rutherford,
NJ, USA). The detailed method of primary culture establishment
can be found elsewhere (Kang et al, 2000). BaP-T, SCC4, SCC9,
SCC15, FaDu, Tu-139, 1483, HEp-2, HeLa, and RKO cells were
cultured as previously described (Rey et al, 2000).
Reverse transcription (RT)–PCR
Total RNA was isolated from the cultured cells using Trizolt
reagent (Invitrogen, Carlsbad, CA, USA) and was subjected to
RNase-free DNase I digestion at 371C for 2h to eliminate any
contaminating genomic DNA. Five mg of DNA-free total RNA was
dissolved in 15mlH 2O, and RT reaction was performed in the first
strand buffer (Invitrogen) containing 300U Superscript II
(Invitrogen), 10mM dithiotrietol, 0.5mg random hexamer (Prome-
ga, Madison, WI, USA), and 125mM dNTP. The annealing reaction
was carried out for 5min at 651C, and cDNA synthesis was
performed for 2h at 371C, followed by incubation for 15min at
701C to stop the enzyme reaction. The RT product was diluted with
70mlH 2O.
To amplify Bmi-1 cDNA, PCR reaction was performed with 2ml
RT product using the following primers: 50-AGCAGAAATGCATC
GAACAA-30 (forward) and 50-CCTAACCAG ATGAAGTTGCTGA-30
(reverse). The PCR amplification was allowed for 30 cycles at
941C (1min)/531C (1min)/721C (1min), followed by 7min
incubation at 721C. This PCR condition with 1ml RT product
allowed for exponential amplification of the starting cDNA. To
control for the contamination with genomic DNA, we also
performed PCR reactions using the samples without prior RT
reaction. No visible amplification was obtained without RT.
Polymerase chain reaction amplifications of GPR1, Cyc2A, MMP-
1, MMP-3, and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) were performed as described previously (Kang et al,
2003).
Western blotting
Whole-cell extracts (WCE) were fractionated by SDS–polyacryl-
amide gel electrophoresis (PAGE) and transferred to Immobilon
protein membrane (Millipore, Billerica, MA, USA). The antibodies
for p16
INK4A (Ab-1) were purchased from Calbiochem (San Diego,
CA, USA), and those for Bmi-1 (H99), b-actin (H-196), and CDK4
(C22) were from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Bmi-1 gene amplification study
Genomic DNA was isolated from five strains of NHOK, two normal
human oral fibroblasts (NHOF), and eight cancer cell lines,
including six OSCC cells. The DNAs were digested with EcoRI and
HindIII to completion, electrophoresed in 0.8% agarose gel, and
transferred to nylon membrane. Bmi-1 genomic sequences were
probed by Southern hybridisation using radiolabelled probe
synthesised from Bmi-1 cDNA or GAPDH cDNA, according to
the methods described elsewhere (Kang et al, 1998). The Bmi-1
radioactive signal was detected by PhosphorImager and quanti-
tated against that of GAPDH. The normalised quantitated values
were used for statistical test (one way ANOVA) to compare the
mean Bmi-1radioactive signals in the NHOK cultures and in the
OSCC cell lines.
Immunohistochemical staining of Bmi-1 in paraffin-
embedded tissues
In situ Bmi-1 expression was determined in oral mucosal tissue
samples with normal (n¼8), dysplastic (n¼9), or cancerous
(n¼10) histopathology obtained from the Oral pathology
diagnostic laboratoryat the University of California at Los Angeles
School of Dentistry. The specimens were collected and processed
according to the guidelines of the University of California at Los
Angeles institutional review board. Immunohistochemistry was
carried out with anti-Bmi-1 antibody (H-99, Santa Cruz, CA, USA)
on 4-mm-thick sections according to the methods described
elsewhere (Kim et al, 2004a). The samples were counterstained
with haematoxylin. Bmi-1 staining intensity per each sample was
arbitrarily scored by an oral pathologist as negative (–), barely
detectable (þ/ ), weak (þ), moderate (þþ), or strong
(þþþ; see 2). In situ Bmi-1 staining was also performed in
cultured NHOK and SCC4 cells according to the previously
described method (Kang et al, 2000).
In situ staining for cellular senescence
Normal human oral keratinocytes cultures infected with the
lentiviral vectors (LV-GFP and LV-Bmi-1i) were fixed in 2%
formaldehyde/0.2%. glutaraldehyde for 3–5min at room tempera-
ture. The cells were then stained for senescence-associated
b-galactosidase (SA b-Gal) activity in freshly prepared staining
solution (Dimri et al, 1995). The presence of SA b-Gal activity was
evidenced by a dark-green colour in the perinuclear cytoplasmic
region.
Lentiviral vector construction and use of short-hairpin
RNA (shRNA)
We utilised the lentivirus-based shRNA expression plasmid pLL3.7
to knockdown the expression of endogenous Bmi-1. The detailed
method of using pLL3.7 to construct the lentivirus expressing
shRNA is described elsewhere (Rubinson et al, 2003). We
constructed pLL3.7-Bmi-1i using double-stranded oligonucleotide
cassette containing the Bmi-1 target sequence (50-AAG-
GAATGGTCCACTTCCATT-30) as described previously (Bracken
et al, 2003). The lentiviral vectors, LV-GFP and LV-Bmi-1i were
prepared by transfecting 293T cells with the RNA interference
(RNAi) plasmids, respectively, pLL3.7 (insertless plasmid) and
pLL3.7-Bmi-1i, using calcium phosphate transfection method in
the presence of the packaging plasmid pCMVDR8.2Vprx, and
the envelope plasmid pCMV-VSV-G (Naldini et al, 1996). We
constructed a lentivirus vector targeting the expression of hTERT
(LV-hTERTi) using the plasmid pLL3.7-hTERTi, which expresses
the shRNA containing the hTERT target sequence (50-
GGCCGATTGTGAACATGGA-30; nucleotides 1947–1965 of the
hTERT mRNA sequence, see GenBank Accession NM 198255). As a
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snegative control, we constructed another lentiviral vector (LV-
Cont.), which expresses nonfunctional shRNA containing the
hTERT mRNA sequences (50- GAACGTGCTGGCCTTCGGC-30;
nucleotides 337–357) that fails to inhibit the endogenous
expression of hTERT. The viral supernatant was collected at 24–
36h after transfection and concentrated by ultracentrifugation, as
previously described (Stewart et al, 1999). Ultracentrifugation led
to the concentration of the original viral supernatant by at least
12.5 fold. Rapidly proliferating NHOK, SCC4, and BaP-T cells were
infected with 1ml of the concentrated virus (LV-GFP, LV-Cont.,
LV-Bmi-1i, and/or LV-hTERTi) in the presence of 6mgml
 1
polybrene for 3h. This infection scheme invariably resulted in
490% infection efficiency determined by the percentage cells
labelled with green fluorescence. The infected cells were photo-
graphed using an inverted epifluorescence microscope (Nikon,
Melvill, NJ, USA).
RESULTS
Bmi-1 is overexpressed in OSCC cells and tissues
To determine the association between Bmi-1 overexpression and
oral carcinogenesis, we compared the expression levels of Bmi-1 in
two independent cultures of NHOK and seven OSCC cells by semi-
quantitative RT–PCR (Figure 1A and Table 1). RKO and HeLa
cells, representing the colorectal and cervical cancer cells,
respectively, were also included for comparison. All tested cancer
cell lines expressed significantly higher level of Bmi-1 compared
with those of NHOK. Replicating NHOK (strain 01-4, population
doubling (PD) 16) expressed higher level of Bmi-1 than the
senescing cells (strain 01-4, PD 18 and 05-1, PD 20). The Bmi-1
expression level was also determined by Western blotting in
NHOK and the OSCC cell lines (Figure 1B). Bmi-1 protein was
weakly detected in NHOK cultured in serum-free KGM and was
not altered by the culture conditions (data not shown). As Bmi-1 is
known to negatively regulate the expression of p16
INK4A in some
cells (Jacobs et al, 1999), we checked for the correlation between
the expression levels of Bmi-1 and p16
INK4A in our experimental
system. Bmi-1 protein expression level was notably higher in most
of the OSCC cell lines compared with that of NHOK, but did not
correlate with the expression level of p16
INK4A, which correlated
more closely with the human papillomavirus (HPV) infection
status (Table 1).
Bmi-1 protein expression in situ was determined by immuno-
histochemical staining of paraffin-embedded oral mucosal tissues
with varying degrees of histopathology that covers the entire
spectrum of oral carcinogenesis (Figure 1C). Bmi-1 protein
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Figure 1 Bmi-1 is overexpressed in the cancer cells derived from OSCC. (A) Endogenous Bmi-1 expression level was compared by semi-quantitative
RT–PCR in NHOK (01–4 and 05–1) and nine cancer cell lines including seven OSCC cell lines. Glyceraldehyde-3-phosphate dehydrogenase was amplified
as a loading control. (B) Western blotting was performed to compare the Bmi-1 protein expression levels in NHOK and OSCC cells. HOK/Bmi-1,
overexpressing exogenous Bmi-1 (Kim et al, 2006), was included as a positive control for Bmi-1 expression. In the same samples, we probed for the level of
p16
INK4A to determine whether aberrant Bmi-1 expression correlated with downregulation of p16
INK4A. b-actin was used as a loading control. (C) In situ
immunohistochemistry was performed with oral mucosal tissue specimens showing the histological features of normal (n¼8), dysplasia (n¼9), and OSCC
(n¼10). The representative examples of histology (left panel, haematoxylin–eosin staining) and the Bmi-1 staining (right panel) are shown in this figure.
Bmi-1 expression was detected by DAB staining (brown color). As negative controls, we included normal and OSCC specimens subjected to the staining
procedure in the absence of specific Bmi-1 antibody (-Bmi-1 Ab). The images were captured with original magnification of  100. (D) NHOK (a–c) and
SCC4 (d–f) cells were fixed, permeabilised, and stained for Bmi-1 by indirect immunoperoxidase method. Bar¼100mm.
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sexpression, revealed by brown 3,30-diaminobenzidine hydrochlo-
ride (DAB) staining, was weakly detectable and limited to the basal
cell layer of normal stratified epithelium (n¼8) and was not found
in the upper spinosum and corneum layers. In contrast, all
preneoplastic oral epithelial tissues (n¼9) displaying mild,
moderate, and severe dysplasia as well as malignant oral lesions
(n¼10) showed elevated Bmi-1 staining compared with those of
the normal tissues (Table 2). The Bmi-1 staining in these aberrant
tissues was detected in most of the epithelial layers containing
viable cells, including stratum basale, spinosum, and granulosum.
Stratum corneum and lucidum did not show Bmi-1 staining owing
to the lack of viable cells in these layers. We also compared the
levels of Bmi-1 staining in situ in cultured normal and cancer cells.
Normal human oral keratinocytes and SCC4 were subjected to
indirect immunopreoxidase staining for Bmi-1 using anti-Bmi-1
antibody. Diffuse cytoplasmic Bmi-1 staining was noted in NHOK,
whereas SCC4 cells showed strong intranuclear and faint
cytoplasmic Bmi-1 staining (Figure 1D). These data are in keeping
with the Western blotting result, which showed notable increase in
the Bmi-1 expression level in SCC4 cells compared with that of
NHOK. The above results indicate that the elevated Bmi-1
expression is associated with preneoplastic oral lesions and is
sustained in oral cancer.
Bmi-1 gene is not amplified in the OSCC cell lines
To determine whether the Bmi-1 overexpression in the OSCC cells
resulted from gene amplification, we compared the amount of
Bmi-1 genomic sequences by Southern blotting in normal and
cancer cells. We included five strains of NHOK, two NHOF strains,
and seven cancer cell lines including six OSCC cell lines. The
Bmi-1-specific signals were obtained at 4.3kb, 3.1kb, and 2.4kb
fragments, and were compared among the tested samples as its
ratio to that of GAPDH (Figure 2). We found that there was no
statistically significant difference in the relative abundance of the
Bmi-1 genomic sequences between the normal and the cancer cells.
The Bmi-1 overexpression in OSCC may result from the mechan-
isms not involving gene amplification, such as promoter activation.
Bmi-1 knockdown inhibits cellular proliferation of normal
and cancer cells
To investigate the biological role of Bmi-1, we knocked down the
expression of endogenous Bmi-1 by RNAi in SCC4 cells and
Table 1 The OSCC cell lines and the status of Bmi-1, p16
INK4A, p53, and
HPV infection
Cells
Tissue
origin Bmi-1
a p16
INK4Ab p53
HPV
status
BaP-T
c gingiva   + Targeted by E6 +/type 16
SCC4
d tongue + + mutant  
SCC9
d tongue +     
SCC15
d tongue +     
HEp-2
d larynx + + Targeted by E6 +/type 18
1483
e oral + + Targeted by E6 +/type 18
FaDu
d pharynx + + Mutant  
Tu139
f larynx +   Mutant  
RKO
g colorectum +   wild-type  
HeLa
d cervix + + Targeted by E6 +/type 18
aBmi-1 overexpression was determined based on the RT–PCR and Western blotting
results (Figure 1). Positive indicates enhanced expression compared with the baseline
(negative) expression level found in the NHOK cultures.
bp16
INK4A expression status
is based on the Western blotting results (Figure 1B).
cTumourigenic counterpart of
NHOK (Park et al, 1995).
dPurchased from American Type Culture Collection. The
protein expression patterns for these cell lines were based on Munro et al, 1999.
eGift of P. Sacks (Univ. Texas, Houston, TX, USA).
fGift of G. Clayman (Univ. Texas,
Houston, TX, USA).
gGift of M. Kastan (Johns Hopkins, Baltimore, MD, USA).
Table 2 Bmi-1 immunoreactivity in situ is elevated in the oral epithelium with dysplastic and cancerous histopathology
Pathologic category Specimen no. Histopathologic finding Bmi-1
a
Normal (n¼8)
b 1 Normal oral epithelium +
2 Normal oral epithelium +/ 
3 Normal oral epithelium +/ 
4 Normal oral epithelium  
5 Normal oral epithelium  
6 Normal oral epithelium +/ 
7 Normal oral epithelium +/ 
8 Normal oral epithelium  
Dysplasia (n¼9)
c 1 Moderate-severe epithelial dysplasia +++
2 Focal keratosis and mild epithelial dysplasia ++
3 Mild epithelial dysplasia +
4 Moderate-severe epithelial dysplasia +++
5 Moderate-severe epithelial dysplasia ++
6 Hyperkeratosis and mild epithelial dysplasia ++
7 Severe epithelial dysplasia +++
8 Mild epithelial dysplasia ++
9 Severe epithelial dysplasia +++
HNSCC (n¼10)
c 1 Moderately differentiated squamous cell carcinoma ++
2 Moderately well differentiated squamous cell carcinoma ++
3 Superficial moderately differentiated squamous cell carcinoma +++
4 Poorly differentiated squamous cell carcinoma ++
5 Moderately differentiated squamous cell carcinoma +
6 Well-differentiated squamous cell carcinoma +
7 Well-differentiated squamous cell carcinoma +
8 Moderately differentiated squamous cell carcinoma ++
9 Well-differentiated squamous cell carcinoma +++
10 Moderately differentiated squamous cell carcinoma +++
aThe level of Bmi-1 immunostaining per each specimen was scored as negative ( ), barely detectable (+/ ), weak (+), moderate (++), or strong (+++) by an oral pathologist,
noting the level of chromogenic development after addition of the DAB substrate. The scoring was confirmed blindly by an individual without prior knowledge or understanding
of the nature of the tissue specimens.
bBmi-1 in normal oral epithelium was limited to the basal cell layer (Figure 1C).
cBmi-1 staining in the dysplastic and the OSCC samples was
homogenously detected in most of the epithelial layers including stratum basale, spinosum, and granulosum (Figure 1C).
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sexponentially replicating NHOK. For this purpose, we constructed
a lentiviral vector (LV-Bmi-1i) capable of expressing shRNA
targeting Bmi-1 using the pLL3.7 plasmid, which also contains the
green fluorescent protein (GFP) expression cassette under a
heterologous promoter (Rubinson et al, 2003). SCC4 cells and
replicating NHOK (strain 05–10, PD 10) were infected with LV-
Bmi-1i and the control lentiviral vector (LV-GFP) expressing GFP
alone. At 3 days post-infection, more than 95% of the cultures
infected with LV-GFP or LV-Bmi-1i demonstrated green fluores-
cence (Figure 3A), indicating efficient infectivity. Also, at 3 days
post-infection, the endogenous Bmi-1 expression level was
decreased by 83 and 85%, respectively, in NHOK and SCC4 cells
infected with LV-Bmi-1i if compared with the cells infected with
LV-GFP (Figure 3B). The SCC4 cells were maintained in culture for
longer than 10 days post-infection, during which time the cells
infected with LV-Bmi-1i showed a marked reduction in proli-
ferative capacity (Figure 3A). The LV-GFP-infected SCC4 cells
continued to replicate beyond the 10-day period, whereas the SCC4
culture exposed to LV-Bmi-1i contained sparse, flattened cells with
GFP expression.
At 3 days post-infection, the majority of NHOK also demon-
strated the fluorescence signal (Figure 4A). Normal human oral
keratinocytes infected with LV-GFP underwent 16 PDs before the
onset of senescence, whereas those infected with LV-Bmi-1i
expressed increased SA b-Gal activity and showed notable
retardation of proliferation following the infection, completing
only 12 cumulative PDs (Figure 4B). To determine whether the
retarded proliferation in NHOK infected with LV-Bmi-1i repre-
sented the cellular senescence response, we compared the
expression levels of GPR1, MMP-1, and MMP-3, which are the
molecular markers of keratinocyte senescence (Kang et al, 2003).
Semi-quantitative RT–PCR was performed with NHOK after 10
days post-infection (Figure 4C). Expression levels of GPR1, MMP-1,
and MMP-3 were induced in NHOK infected with LV-Bmi-1i
compared with those infected with LV-GFP. Also, the cells with
Bmi-1 knockdown showed diminution of Cyc2A mRNA, of which
the expression level is associated with exponential replication of
NHOK (Kang et al, 2003). However, the cells infected with
LV-Bmi-1i did not exhibit elevation of p16
INK4A (Figure 4D). These
results demonstrated that the loss of endogenous Bmi-1 expression
led to diminution of the cell proliferation capacity in both SCC4
cells and NHOK, in the absence of induced p16
INK4A expression
level.
The involvement of the p16
INK4A in the cell proliferation arrest
triggered by Bmi-1 knockdown was further analysed by utilising
the BaP-T cells, which possess aberrant p16
INK4A/pRb pathway
owing to the expression of HPV oncoprotein E7 (Park et al, 1995).
Actively proliferating BaP-T cells were infected with LV-GFP or
LV-Bmi-1i vectors. For comparison, we also infected the cells
with LV-hTERTi, targeting the cellular telomerase activity, which
demonstrated effective anticancer activity (Li et al, 2004). The
cells were maintained in culture for 10 days post-infection, and
the total numbers of the infected cells were determined. All of the
lentiviral vectors demonstrated highly efficient infectivity even
after 1 day post-infection (Figure 5). However, infection of BaP-T
cells with LV-Bmi-1i or LV-hTERTi effectively inhibited cellular
proliferation and led to loss of viability as early as 4 days post-
infection (Figure 6). BaP-T cells were also infected with LV-Cont.
expressing nonfunctional shRNA against hTERT sequence. These
cells exhibited no phenotypic alteration compared with those
infected with LV-GFP (Figure 5D). These results suggest that
the intact p16
INK4A/pRb checkpoint pathway is not necessary for
the Bmi-1i-induced OSCC replication arrest and death.
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Figure 3 Inhibition of endogenous Bmi-1 causes replication arrest in
SCC4 cells. (A) Rapidly proliferating SCC4 cells were infected with LV-GFP
or LV-Bmi-1i. After 3 or 10 days, the images were obtained for GFP
revealing those cells that were originally infected by the viral vectors.
Original magnification,  100. (B) Three days after infection of NHOK (05-
10) and SCC4 cells with LV-GFP or LV-Bmi-1i, the level of Bmi-1 transcript
was measured by semi-quantitative RT–PCR. The extent of Bmi-1
knockdown by LV-Bmi-1i was quantitated by Scion Image software against
those of GAPDH amplification.
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Figure 2 Bmi-1 gene is not amplified in OSCC. Genomic DNAs from
five different NHOK strains, two NHOF strains, and seven cancer cell lines
were digested with EcoR I and Hind III and transferred for probing.
Radiolabelled probes synthesised from Bmi-1 or GAPDH cDNA were
hybridised sequentially onto the membrane. The phosphometric intensities
were plotted as the ratio of Bmi-1 to GAPDH. The lack of statistical
difference (P40.05) in the levels of Bmi-1radioactive signals was
determined by unpaired T-test (one-ways ANOVA) between the NHOK
and the cancer groups.
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In the present study, we examined the possible involvement of the
PcG protein Bmi-1 in oral carcinogenesis by (1) comparison of the
Bmi-1 protein and RNA expression levels in normal and OSCC
cells and tissues and (2) knockdown of endogenous Bmi-1 in
normal and OSCC cells. The first part of the study revealed that
Bmi-1 overexpression was consistently observed in the OSCC cells
and tissues compared with the normal controls. The level of Bmi-1
expression in the OSCC cells was comparable to that of the cancer
cells, that is, RKO and HeLa, derived from other cancer types.
Importantly, Bmi-1 overexpression was also observed in 100% (9/
9) of the preneoplastic oral mucosal tissues which included those
with mild, moderate, or severe epithelial dysplasia. This finding
indicates that Bmi-1 overexpression occurs very early during oral
carcinogenesis and may be used as a biomarker of preneoplastic
oral lesions. A recent study examined the expression status of
Bmi-1 in the lung SCC precursor lesions, which showed Bmi-1
expression in 48% of the cases by immunofluorescent staining
(Breuer et al, 2005). Thus, Bmi-1 overexpression and the
development of preneoplastic lesions are more closely associated
in the oral mucosa than in the bronchial tissues.
The mechanism leading to the enhanced Bmi-1 expression in
OSCC cells is not clear. However, we ruled out the possibility of
gene amplification by Southern blotting, which showed compar-
able level of Bmi-1 genomic sequences in normal and OSCC cells.
Using the Bmi-1 promoter-luciferase construct, we found that the
promoter activity was strongly induced in the OSCC cells
compared with that of NHOK (unpublished observation), indicat-
ing that Bmi-1 overexpression results from promoter activation.
Recent studies showed that Bmi-1 is a direct transcriptional target
of c-Myc in human fibroblasts (Guney et al, 2006) and of E2F-1 in
neuroblastomas (Nowak et al, 2006). c-Myc was found to be
frequently amplified in OSCCs by comparative genomic hybridisa-
tion (Chen et al, 2004). Thus, c-Myc-dependent Bmi-1 promoter
activation may account for the enhanced gene expression during
dysplastic cell transformation in oral carcinogenesis, although the
extent to which c-Myc regulates the Bmi-1 promoter activity in oral
carcinogenesis needs further investigation.
Bmi-1 knockdown led to inhibition of cellular replication in
both NHOK and OSCC cells. However, the cellular response seems
to be different between the normal and cancer cells. In NHOK,
Bmi-1 knockdown did not elicit an immediate response of
replication arrest and/or loss of viable cells, although the cellular
replication rate was notably reduced and the senescence prema-
turely triggered. In contrast, SCC4 and BaP-T cells underwent
rapid arrest of replication upon infection with LV-Bmi-1i and
showed drastic decrease in the viable cell number. After 8–10 days
post-infection, the majority of the OSCC cells detached from the
culture dish (Figures 3A and 5). Comparison of the replication
kinetics of the cells infected with the LV-GFP or LV-Bmi-1i also
demonstrates clear difference in the cellular response between
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Figure 4 Inhibition of endogenous Bmi-1 causes premature senescence in NHOK. (A) Rapidly proliferating NHOK (05-10) was infected with LV-GFP or
LV-Bmi-1i. Phase contrast photographs, SA b-Gal staining, and GFP fluorescence were obtained 10 days after virus infection. Original magnification,  100.
(B) Proliferation kinetics of NHOK infected with LV-GFP or LV-Bmi-1i was determined and plotted against time in culture. (C) NHOK cultures were
harvested at 10 days after infection with LV-GFP or LV-Bmi-1i, and the expression levels of GPR1, Cyc2A, MMP-1, and MMP-3 were determined by semi-
quantitative RT–PCR. The band intensities were quantitated and plotted by Scion Image software against those of GAPDH amplification. (D) NHOK (05-
10) and SCC4 cells infected with LV-GFP or LV-Bmi-1i were harvested at 10 days after infection, and Western blotting was performed with 100mg WCE for
p16
INK4A. CDK4 was detected as a loading control.
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consistent with a recent report demonstrating cancer-specific
cytotoxic effect of Bmi-1 knockdown in neuroblastoma cells (Liu
et al, 2006). The differential effect of Bmi-1 knockdown in the
normal and cancer cells may be beneficial if Bmi-1 were to be
targeted for anticancer therapy.
The LV-Bmi-1i vector was effective against the BaP-T cells,
which express HPV type 16 E7 (Park et al, 1995). Thus, Bmi-1i-
mediated growth inhibition may not require intact p16
INK4A/pRb
checkpoint pathway, as it is also reflected in the absence of
p16
INK4A induction in the NHOK and SCC4 cells after Bmi-1
knockdown. The inverse correlation between Bmi-1 and p16
INK4A
protein expression levels was not evident in the OSCC cell lines in
our study (Figure 1B). Furthermore, we recently reported that
expression of exogenous Bmi-1 in NHOK led to significant
extension (2.7 fold) of replicative life span but did not efficiently
downregulate the expression of p16
INK4A (Kim et al, 2006). It is
possible that Bmi-1 targets other important regulators of cell
division in NHOK, such as p14
ARF or p15
INK4B, as previously
suggested (Jacobs et al, 1999). Several recent studies also showed
that the aberrant Bmi-1 expression is not necessarily associated
with downregulation of p16
INK4A expression (Dukers et al,
2004; Breuer et al, 2005). Also, Bracken et al (2006) recently
identified numerous cellular genes targeted by Bmi-1 other than
p16
INK4A using microarray-based expression screening and
chromatin immunoprecipitation (ChIP)-on-chip analysis. These
findings support the possibility that Bmi-1 elicits its oncogenic
property during oral carcinogenesis in p16
INK4A-independent
manner.
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Figure 6 Effective loss of viability in BaP-T cells infected with LV-Bmi-1i
or LV-hTERTi. Viable BaP-T cells infected with LV-GFP, LV-Bmi-1, or LV-
hTERTi shown in Figure 5 were quantitated and plotted against period of
culture. The total numbers of fluorescence-labelled adherent cells were
determined at 3, 5, 6, 8, and 10 days post-infection.
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